Bragar Eagel & Squire Reminds Ardent Health Shareholders of Lawsuit Deadline

Investors have until March 9, 2026 to apply to be lead plaintiff in class action lawsuit against Ardent Health.

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

Bragar Eagel & Squire, P.C., a national law firm, has filed a class action lawsuit against Ardent Health, Inc. on behalf of shareholders who purchased or acquired Ardent Health securities between July 18, 2024 and November 12, 2025. The lawsuit alleges that Ardent Health reported higher accounts receivable and delayed recognizing losses on uncollectable accounts during this period.

Why it matters

The lawsuit claims Ardent Health's actions misled investors about the company's financial health, leading to a significant stock price drop when the issues were revealed. This case highlights the importance of accurate financial reporting and transparency for publicly traded companies.

The details

According to the complaint, on November 12, 2025, Ardent Health revealed a $43 million decrease in third quarter 2025 revenue due to revised determinations of accounts receivable collectability after the company transitioned to a new revenue accounting system. This news caused Ardent Health's stock price to fall nearly 34% on November 13, 2025.

  • The class period is from July 18, 2024 to November 12, 2025.
  • Investors have until March 9, 2026 to apply to the court to be appointed as lead plaintiff in the lawsuit.

The players

Bragar Eagel & Squire, P.C.

A nationally recognized stockholder rights law firm that filed the class action lawsuit against Ardent Health.

Ardent Health, Inc.

A publicly traded healthcare company that is the defendant in the class action lawsuit.

Got photos? Submit your photos here. ›

What they’re saying

“If you purchased or otherwise acquired Ardent Health shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato.”

— Brandon Walker, Litigation Partner, Bragar Eagel & Squire (Bragar Eagel & Squire)

What’s next

Investors have until March 9, 2026 to apply to the court to be appointed as lead plaintiff in the lawsuit against Ardent Health.

The takeaway

This case highlights the importance of accurate financial reporting and transparency for publicly traded companies. Investors who suffered losses from Ardent Health's alleged misconduct are encouraged to contact Bragar Eagel & Squire to discuss their legal options.